Appointment booking for Dr. Vitune Vongtama, MD is currently not available.Dr. Vitune Vongtama, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Vitune Vongtama, MD (he/him) is a Radiologist in Stockton, CA with over 18 years of experience. What is your opinion of Dr. Vitune Vongtama, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Vitune Vongtama, MD has received over $4,421 which includes payments from the following companies:
$1,293.88 from Janssen Pharmaceuticals, Inc
$1,098.55 from AstraZeneca Pharmaceuticals LP
$357.87 from sanofi-aventis U.S. LLC
$253.22 from Gilead Sciences Inc
$207.05 from Teva Pharmaceuticals USA, Inc.
$171.61 from Incyte Corporation
$159.25 from Novo Nordisk Inc
$158.42 from Boehringer Ingelheim Pharmaceuticals, Inc.
$103.87 from Covidien Sales LLC
$100.00 from E.R. Squibb & Sons, L.L.C.
$90.00 from LILLY USA, LLC
$87.15 from Medtronic Vascular, Inc.
$84.50 from Novartis Pharmaceuticals Corporation
$76.20 from INSYS Therapeutics Inc
$75.49 from Takeda Pharmaceuticals America, Inc.
$59.46 from Regeneron Pharmaceuticals, Inc.
$45.44 from Augmenix, Inc.
Payments received by Dr. Vitune Vongtama, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!